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The arenavirus envelope glycoprotein (GP-C) retains a cleaved and stable signal peptide (SSP) as an essential subunit of the mature complex.
This 58-amino-acid residue peptide serves as a signal sequence and is additionally required to enable transit of the assembled GP-C complex to the
Golgi, and for pH-dependent membrane fusion activity. We have investigated the C-terminal region of the Junín virus SSP to study the role of the
cellular signal peptidase (SPase) in generating SSP. Site-directed mutagenesis at the cleavage site (positions −1 and −3) reveals a pattern of side-
chain preferences consistent with those of SPase. Although position −2 is degenerate for SPase cleavage, this residue in the arenavirus SSP is
invariably a cysteine. In the Junín virus, this cysteine is not involved in disulfide bonding. We show that replacement with alanine or serine is
tolerated for SPase cleavage but prevents the mutant SSP from associating with GP-C and enabling transport to the cell surface. Conversely, an
arginine mutation at position −1 that prevents SPase cleavage is fully compatible with GP-C-mediated membrane fusion activity when the mutant
SSP is provided in trans. These results point to distinct roles of SSP sequences in SPase cleavage and GP-C biogenesis. Further studies of the
unique structural organization of the GP-C complex will be important in identifying novel opportunities for antiviral intervention against
arenaviral hemorrhagic disease.
© 2006 Elsevier Inc. All rights reserved.Keywords: Arenavirus; Envelope glycoprotein; Signal peptide; Trafficking; Membrane fusionIntroduction
The arenaviruses comprise a family of enveloped, negative-
strand RNA viruses whose species are spread and diversified
worldwide in association with their rodent hosts (Salazar-Bravo
et al., 2002). Old World and New World arenaviruses are
phylogenetically distinct yet closely related (Clegg, 2002).
Although many arenavirus species are apparently not patho-
genic to humans, several can be transmitted to cause severe
acute hemorrhagic fevers (McCormick and Fisher-Hoch, 2002;
Peters, 2002). Up to 300,000 infections by Lassa fever virus
occur in Africa annually (McCormick et al., 1987), while
outbreaks of the South American hemorrhagic fever species
Junín, Machupo, and Guanarito are more sporadic (Peters,
2002). In the absence of effective treatment or immunization,⁎ Corresponding author. Fax: +1 406 243 6425.
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doi:10.1016/j.virol.2006.08.048these viruses remain an urgent public health and biodefense
concern.
Arenavirus entry into its target cell is mediated by the GP-C
envelope glycoprotein. The mature GP-C complex is unusual
among viral envelope glycoproteins in that it consists of three
noncovalently associated subunits: in addition to the receptor-
binding (G1) and transmembrane fusion (G2) subunits, the
complex retains a cleaved but stable signal peptide (SSP)
(Buchmeier, 2002; Eichler et al., 2003a; York et al., 2004)
(Fig. 1). The 58-amino-acid SSP is likely generated by signal
peptidase (SPase) cleavage of the GP-C precursor, and the
mature G1 and G2 subunits are subsequently produced by
SKI-1/S1P protease cleavage of the G1–G2 precursor
glycoprotein (Beyer et al., 2003; Kunz et al., 2003; Lenz et
al., 2000). SKI-1/S1P maturation of the G1–G2 precursor is
required for membrane fusion activity (Kunz et al., 2003; Lenz
et al., 2001; York et al., 2004) and takes place in the cis-medial
Golgi compartment (DeBose-Boyd et al., 1999; Elagoz et al.,
2002). Transport of GP-C from the endoplasmic reticulum
Fig. 1. Schematic representation of the Junín virus GP-C glycoprotein and SSP sequences. Amino acids of the Junín virus envelope glycoprotein are numbered from
the initiating methionine, and cysteine residues (∣) and potential glycosylation sites (Y) are marked. The SSP and SKI-1/S1P cleavage sites, and the resulting SSP, G1
and G2 subunits are indicated. Within G2, the C-terminal transmembrane (TM) and cytoplasmic (cyto) domains are shown, as are the N- and C-terminal heptad-repeat
regions (light gray shading). A comparison of SSP sequences among arenavirus species is detailed below. Sequences include the NewWorld isolates Junín (D10072),
Tacaribe (M20304), Pichindé (U77601), Machupo (AY129248), and Sabiá (YP_089665) and Old World isolates Lassa–Nigeria (X52400), Mopeia (M33879), and
LCMV-Armstrong (M20869). The two hydrophobic (hϕ) regions are highlighted in gray.
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the GP-C complex (Agnihothram et al., 2006; Eichler et al.,
2003a; York et al., 2004). SSP binding has been shown to
overcome ER localization signals present in the cytoplasmic
domain of G2 and thereby ensure that only the fully assembled
complex is transported to the plasma membrane (Agnihothram
et al., 2006), where viral budding occurs (Perez et al., 2003;
Strecker et al., 2003). This quality control function of SSP
suggested that SSP is a required component of the mature
complex. Recent studies have demonstrated a direct role of the
SSP subunit in modulating pH-dependent membrane fusion by
the tripartite GP-C complex (York and Nunberg, 2006).
Here we investigate the sequence requirements for proteo-
lytic processing of the GP-C precursor glycoprotein to generate
SSP. We show that amino acids substitutions at positions −3
(S56) and −1 (T58) from the SSP cleavage site either prevent
(T58R) or enhance (S56A and T58A) cleavage, in accordance
with predictions based on recognition by the cellular SPase.
Substitutions at position −2 are tolerated for SPase cleavage
(C57A and C57S) but prevent association of the mutant SSPs
with GP-C. In contrast, engineered SSP peptides bearing either
the T58R mutation or a C-terminally appended affinity tag are
able to associate with and support pH-dependent membrane
fusion activity of the GP-C complex. While further supporting
the role of SPase in the generation of SSP, these studies also
point to the need to elucidate the unusual structure–function
relationships that control the biogenesis and membrane fusion
activity of the tripartite GP-C complex.
Results
Junín virus SSP and GP-C biogenesis
The amino acid sequences of GP-C of New World and Old
World arenaviruses reveal several important and well-conserved
features in SSP (Fig. 1). In addition to the N-terminal
myristoylation motif (GX3S/T; York et al., 2004), the SSPsencode two hydrophobic regions (Eichler et al., 2004;
Froeschke et al., 2003). In conventional signal peptides
containing a single hydrophobic domain, SPase cleavage
typically occurs 5–6 amino acids C-terminally from the
hydrophobic span (von Heijne, 1985); in the GP-C precursor
cleavage takes place beyond the second hydrophobic region in
SSP, at position 58 (Buchmeier, 2002; Eichler et al., 2003b).
Although SSP is clearly membrane associated, it is unclear
which of the hydrophobic region(s) ultimately resides in the
membrane (Eichler et al., 2004; Froeschke et al., 2003).
Mutational studies at the cleavage site of the Lassa virus GP-C
nonetheless suggest that SSP cleavage is mediated by SPase
(Eichler et al., 2003b). Arginine substitutions at either the −1 or
−3 position from the SSP cleavage site in the Lassa fever virus
GP-C (S56R or T58R) were shown to prevent SSP cleavage, in
accordance with the requirements for SPase recognition (von
Heijne, 1985).
To investigate SSP cleavage in the New World arena-
viruses, we mutated amino acids in proximity of the SSP C-
terminus in the GP-C precursor of Junín virus. The mutant
glycoproteins were then analyzed to determine the effects of
the mutations on SSP cleavage and GP-C biogenesis (York et
al., 2004, 2005). In brief, the Junín virus GP-C glycoprotein
was expressed and metabolically labeled in Vero cells and
immunoprecipitated from cell lysates using the G1-directed
monoclonal antibody (MAb) BE08 (Sanchez et al., 1989).
The pattern of wild-type GP-C expression has previously
been characterized by sodium dodecylsulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) (Agnihothram et al., 2006;
York et al., 2004, 2005; York and Nunberg, 2006) and is
briefly summarized here for comparison. Immunoprecipitation
reveals a major band of 60 kDa (the G1–G2 precursor), the
mature G1 and G2 subunits (as a heterodisperse smear of 30–
40 kDa), and the associated SSP (Fig. 2A top panel, lane 2).
Maturation of the G1–G2 precursor by SKI-1/S1P protease is
incomplete (York et al., 2004, 2005), presumably due to
saturation of host cell cleavage pathways upon over-
74 J. York, J.H. Nunberg / Virology 359 (2007) 72–81expression. Deglycosylation of the glycoproteins using
peptide:N-glycosidase F (PNGase F) allows for identification
of the G1 and G2 subunits as the respective 22- and 27-kDa
polypeptides, as well as for resolution of a GP-C precursor
bearing the uncleaved SSP (York et al., 2004), which migrates
slightly larger than the G1–G2 precursor (52- vs. 50-kDapolypeptides, respectively) (bottom panel, lane 2). Incomplete
cleavage of SSP also occurs in cells over-expressing GP-C of
the Old World Lassa fever and LCM viruses (Eichler et al.,
2003b; Froeschke et al., 2003). By this analysis of the
deglycosylated precursors, the relative extent of SSP cleavage
in GP-C mutants can be evaluated.
75J. York, J.H. Nunberg / Virology 359 (2007) 72–81Arginine substitution at position −1 in SSP of the Junín virus
GP-C prevents cleavage and transport to the cell surface
We initially examined the T58R mutation that had been
shown to abrogate SSP cleavage in the Lassa fever virus (Eichler
et al., 2003b). Consistent with the report in the Old World virus,
SSP cleavage of Junín virus GP-C was absent in the T58R
mutant. SSP was not co-precipitated with the GP-C complex
(Fig. 2A top panel, lane 7) and only the GP-C precursor was
evident in the deglycosylated sample (bottom panel). As also
noted in the Lassa fever virus (Eichler et al., 2003b), the T58R
mutation in Junín virus resulted in failure of the GP-C precursor
to undergo SKI-1/S1P-mediated maturation (bottom panel).
Based on the importance of SSP in regulating transit of the
GP-C complex from the ER (Agnihothram et al., 2006), it is
possible that the lack of SKI-1/S1P cleavage derives from a
failure of the GP-C precursor to be transported to the Golgi, the
location of the activated SKI-1/S1P protease (DeBose-Boyd et
al., 1999; Elagoz et al., 2002). Alternatively, the presence of the
uncleaved SSP might prevent maturation by masking or
conformationally altering the SKI-1/S1P recognition site,
without affecting transport of the GP-C complex (Eichler et
al., 2003b). Mutations that inactivate the SKI-1/S1P recognition
sequence, for instance, do not by themselves prevent transit to
the cell surface (Beyer et al., 2003; Kunz et al., 2003; York et al.,
2005). To investigate the basis for the lack of SKI-1/S1P
cleavage in the T58R mutant, we utilized flow cytometry to
determine whether the mutant GP-C was transported to the cell
surface. In studies using the G1-directed MAb BE08 (Agniho-
thram et al., 2006; York et al., 2005), the T58R GP-C mutant
was not detected on the cell surface (Fig. 2C). The lack of
transport to the surface suggests that the T58R GP-C precursor
may also fail to transit to the Golgi.
Alanine substitutions at positions −1 and −3 enhance SSP
cleavage
The disruption of SSP cleavage by an arginine substitution at
position −1 is consistent with recognition by SPase (Eichler et
al., 2003b). To further probe the requirements for SSP cleavage,
we mutated the residues at positions −1 and −3 in GP-C (T58
and S56, respectively) to alanine, the amino acid that is most
frequently represented at these positions in SPase cleavage sites
(von Heijne, 1985). In contrast to T58R, the alanine mutation
enhanced SPase cleavage; considerably more of the G1–G2Fig. 2. Expression of GP-C is affected by mutations in SSP. (A and B) Metabolically
(Sanchez et al., 1989) and separated on NuPAGE 4–12%Bis–Tris gels (top panels). In
both the G1 and G2 polypeptides and the GP-C and SPase-cleaved G1–G2 precurso
efficiency of SPase cleavage. Known GP-C species are labeled at left; minor unident
protein markers (Amersham Biosciences) are indicated (in kilodaltons). In panel (
examined. The wild-type (wt) and SKI-1/S1P cleavage-defective (cd) glycoprotei
complementation studies are shown in panel (B). In these studies, the CD4sp-GPC co
alone (lane 1) or with the wild-type SSP (+wt SSP; lane 2). The SSP component was
from SPase cleavage of cd-GPC in lane 5, and as the affinity-tagged T58R SSP-Spep
and T58R with wild-type SSP are depicted in lanes 7 and 8, respectively. In panel (C),
using MAb BE08. The cell population was stained using propidium iodide (1 μg
FACSCalibur flow cytometer (BD Biosciences). Background staining of mock-tra
populations.precursor polypeptide was found relative to the GP-C
polypeptide in the T58A mutant than in the wild-type GP-C
(Fig. 2A bottom panel, lane 6). Quantitative analysis of the
phosphorimages revealed that 75% of the T58A precursor
polypeptides were as G1–G2, relative to 40% in the wild type.
Cleavage was also enhanced by the S56A mutation (to 60% in
G1–G2). These increases in cleavage likely reflect the
preference for alanine at positions −1 and −3 at SPase
recognition sites, and are in turn consistent with the notion
that cleavage to generate SSP is mediated by SPase.
The increase in SPase cleavage of S56A and T58AGP-C was
not manifested in a significant increase in cell surface expression
as detected by flow cytometry (Fig. 2C). To determine whether
these mutations might affect the ability of GP-C to mediate
membrane fusion, we examined pH-dependent cell–cell fusion
using a β-galactosidase fusion reporter assay (Nussbaum et al.,
1994). In this assay (York et al., 2004, 2005), activation of GP-C-
mediated membrane fusion by acidic pH (pH 5.0) results in
syncytium formation between the GP-C-expressing effector
cells and the β-galactosidase reporter cells. The induced β-
galactosidase activity is monitored using a chemiluminescent
substrate. As shown in Fig. 3, the alanine substitution at position
−3 (S56A) had no effect on cell–cell fusion.
By contrast, cells expressing T58A GP-C were seven-fold
more fusogenic than those expressing the wild-type glycopro-
tein. The increase in cell–cell fusion by the T58A mutation, in
the absence of a significant increase in cell surface expression,
suggests that the alanine substitution may be directly important
in enhancing membrane fusion. Alternatively, cell–cell fusion
may be increased by affecting the ratio of SSP-cleaved vs.
uncleaved glycoproteins in the oligomeric spikes (Yang et al.,
2006). In any case, the potential for cell–cell fusion appears
limited by the naturally occurring threonine at position 58, and
can be enhanced by substituting alanine. Whether these
observations extend to the virion life cycle is unknown (see,
e.g., Lee et al., 2000).
C57 at position −2 is dispensable for cleavage but required for
SSP association in the GP-C complex
Although conventional signal peptides display marked
preferences for specific side-chains at positions −1 and −3, a
broad range of amino acids is found at position −2 (Nielsen et
al., 1997). In the arenavirus SSP, this position is invariably
cysteine (Fig. 1). C57 is the sole cysteine residue in SSP of thelabeled glycoproteins were immunoprecipitated using a G1-specific MAb BE08
the bottom panels, the glycoproteins were first treated with PNGase F to resolve
rs. The relative amount of G1–G2 vs. GP-C precursors was used to estimate the
ified and incompletely deglycosylated bands are also present. The [14C]-labeled
A), mutations at positions −3, −2 and −1 from the SPase site in GP-C were
ns (lanes numbered 2 and 8, respectively) are shown for comparison. Trans-
nstruct containing the conventional signal peptide of human CD4 was expressed
provided to CD4sp-GPC as C57S and T58R SSP in lanes 3 and 4 respectively,
in lane 6. Trans-complementation studies using full-length GP-C mutants C57S
cell surface expression of GP-C in Vero cells was determined by flow cytometry
/ml) to exclude dead cells. Formaldehyde-fixed cells were analyzed using a
nsfected cells is shown to identify non-expressing cells in the transfected cell
Fig. 3. pH-dependent cell–cell fusion activity. pH-dependent syncytium forma-
tion was detected using the recombinant vaccinia virus-based β-galactosidase-
reporter assay (Nussbaum et al., 1994) as previously described (York et al.,
2005; York et al., 2004). β-Galactosidase expression induced upon syncytium
formation was quantitated using the chemiluminescent substrate GalactoLite
Plus (Tropix). pH-dependent relative light unit (RLU) measurements are shown
after subtraction of background levels from neutral-pH cultures. The variance
and estimated standard deviation of the difference (typically 2–4%) was
calculated and error bars (where discernible on the scale of the graph) are
drawn. The left panel displays cell–cell fusion by the full-length GP-C
constructs described in Fig. 2A. The right panel represents trans-complemen-
tation studies using constructs described in Fig. 2B. Experiments are grouped
(by horizontal lines above their descriptors and by shades of gray) to
correspond with the text.
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bonding (York et al., 2004). To assess the role of C57 at the −2
position of the SSP cleavage site, we replaced the cysteine side-
chain with those of either alanine or serine. Both C57A and
C57S mutants were subjected to cleavage, as evidenced by the
mixture of GP-C and G1–G2 precursors (Fig. 2A bottom panel,
lanes 4 and 5). Quantitative analysis of these precursors indi-
cated a ratio identical to that of the wild type (40% as G1–G2).
This allowed degeneracy at the −2 position is again consistent
with SPase cleavage.
However, neither of the mutant SSPs was co-precipitated
with the GP-C complex (Fig. 2A top panel, lanes 4 and 5), nor
was either able to support SKI-1/S1P maturation of the G1–G2
precursor (bottom panel). The lack of SKI-1/S1P cleavage is
likely secondary to the failure of SSP to associate with the G1–
G2 precursor and enable transport through the Golgi (Agniho-
thram et al., 2006). In keeping with this suggestion, the C57
mutants were not transported to the cell surface (Fig. 2C), and
did not mediate cell–cell fusion (Fig. 3).
Confirmation that SPase cleavage per se was unaffected by
substitutions at C57 was obtained in trans-complementation
studies. We and others have shown that co-expression of the 58-
amino-acid SSP in trans with a recombinant G1–G2 precursor
bearing a conventional signal peptide is able to rescue the
assembled complex from the ER and fully restore SKI-1/S1P-
mediated maturation, cell surface expression, and membrane
fusion activity (Agnihothram et al., 2006; Eichler et al., 2003a;
York and Nunberg, 2006; York et al., 2004). In the absence of
SSP in trans, a G1–G2 precursor expressed using the signal
peptide of human CD4 (CD4sp-GPC (Agnihothram et al., 2006;York et al., 2004)) was not subject to significant SKI-1/S1P
maturation; co-expression of the wild-type SSP as a 58-amino-
acid fragment (SSP-term) restored GP-C assembly, transport,
and SKI-1/S1P proteolytic processing (Fig. 2B, lanes 1 and 2).
Thus, we asked whether the C57S GP-C precursor could also
serve as a source of G1–G2 precursor. As shown in Fig. 2B, co-
expression of C57S GP-C with SSP-term allowed for
association and SKI-1/S1P cleavage of the G1–G2 precursor
(lane 7). Furthermore, the trans-complemented GP-C complex
was now able to mediate cell–cell fusion (Fig. 3). Thus, the
C57S mutation in GP-C does not prevent SSP cleavage and
production of a viable G1–G2 precursor.
Interestingly, rescue of C57S GP-C was entirely dependent
on SPase cleavage of the GP-C precursor. Retention of SSP in
the uncleaved T58R GP-C precursor prevented trans-associa-
tion of the wild-type SSP-term (Fig. 2B top panel, lane 8) and
failed to rescue SKI-1/S1P cleavage of the T58R GP-C
precursor (bottom panel) or membrane fusion activity (Fig. 3).
It is unclear whether prior binding of the uncleaved SSP of
T58R GP-C precludes trans-complementation or whether
SPase cleavage of the GP-C precursor is required for proper
association of SSP.
We conversely confirmed the inability of C57S SSP to
associate with its G1–G2 precursor in trans-complementation
studies using a C57S mutant of SSP-term and the wild-type
G1–G2 precursor of CD4sp-GPC. C57S SSP-term did not
associate with the G1–G2 precursor and failed to promote
significant SKI-1/S1P cleavage (Fig. 2B, lane 2). These defects
were reflected in its failure to rescue cell surface expression
(Fig. 2C) or membrane fusion activity (Fig. 3). Thus, although
conservative mutations at the –2 position were well tolerated for
SSP cleavage, as anticipated based on the natural variability at
this position in SPase recognition sites, the resulting SSPs were
unable to associate with the G1–G2 precursor.
C57 does not appear to be involved in disulfide bonding
The requirement for C57 in SSP association cannot be
readily attributed to its potential for disulfide bonding. C57 is
the sole cysteine in the Junín virus SSP, which migrates as a free
monomer in the recombinantly expressed GP-C complex upon
SDS-PAGE analysis under non-reducing conditions (York et al.,
2004). To investigate whether C57 might participate in disulfide
bonding in the native virion, we studied the attenuated strain of
the Junín virus, Candid #1 (Albarino et al., 1997; Barrera Oro
and McKee, 1991; Maiztegui et al., 1998). The GP-C of Candid
#1 is identical to that of the pathogenic Junín virus, except for
two conservative amino acid changes in or near the transmem-
brane domain of G2 (F427I and T446S).
Candid #1-infected Vero cells were metabolically labeled
and virions were purified from the cell culture supernatant by
ultracentrifugation through 20% sucrose. Upon lysis of the
pellet and immunoprecipitation using the anti-G1 MAb BE08,
the GP-C glycoproteins were analyzed by SDS-PAGE, under
reducing or non-reducing conditions (Fig. 4). The pattern of
distinct G1 and G2 glycoproteins and SSP in the virions was
identical in both cases, with the exception that the non-reduced
Fig. 4. Candid #1 virions contain noncovalently associated SSP. Metabolically
labeled Candid #1 virions were purified by ultracentrifugation and virion GP-C
was isolated by immunoprecipitation using the G1-specific MAb BE08
(Sanchez et al., 1989). The glycoproteins were analyzed by denaturing PAGE
under reduced or non-reduced conditions (Invitrogen). Phosphorimages were
quantitated using ImageGauge software (Fuji) and the relative percentage of
radioactivity in SSP was determined (4% and 3% respectively). Although SSP
includes 7% of the total cysteines and methionines in GP-C, our use of the [35S]-
ProMix mixture precludes calculation of relative specific activities.
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reduced subunits. The relative amount of SSP was determined
by quantitative analysis of the phosphorimages and found to be
similar under reducing and non-reducing conditions (4% and
3% of the total radioactivity, respectively). Thus, we found no
evidence that SSP is involved to an appreciable extent in
disulfide bond formation in the native virion particle. Whereas
these studies do not exclude the possibility that disulfide bond
formation might be subsequently involved during pH-depen-
dent membrane fusion (Wallin et al., 2004), they do demonstrate
that SSP association in the virion GP-C complex is not mediated
by disulfide bonding.
The C-terminus of SSP can be modified without affecting SSP
association or function
Although the T58R mutation in GP-C prevented SSP
cleavage, the arginine substitution surprisingly did not affect
the ability of T58R SSP-term to associate with the G1–G2
precursor of CD4sp-GPC in trans-complementation studies
(Fig. 2B top panel, lane 4). Expression of T58R SSP allowed for
SKI-1/S1P processing of the G1–G2 precursor (bottom panel),
transport of the complex to the cell surface (Fig. 2C), and wild-
type levels of cell–cell fusion activity (Fig. 3). Despite the strict
requirement for the penultimate C57, the large positively
charged side-chain of arginine at position 58 was well tolerated
for SSP function.
The observations that T58 could be replaced by arginine in
SSP-term without significant effect on membrane fusion led us
to explore the limits of modifications at the C-terminus of SSP.
We have previously shown that a 15-amino-acid S-peptide(Spep) affinity tag (Kim and Raines, 1993) could be fused to the
cytoplasmic C-terminus of G2 in GP-C without perturbing the
biogenesis or function of the complex (Agnihothram et al.,
2006; York et al., 2004, 2005). To determine whether this same
tag on SSP might be compatible with function, we appended
Spep to the C-terminus of the T58R SSP mutant (T58R SSP-
Spep). As judged by its migration in SDS-PAGE (Fig. 2B top
panel, lane 6), the T58R mutation prevented SPase cleavage of
the SSP fusion protein as it had in GP-C. Nonetheless, T58R
SSP-Spep was fully able to associate with GP-C, restore SKI-1/
S1P processing (bottom panel), and rescue membrane fusion
activity (Fig. 3). Whereas the structure–function relationships at
the C-terminus of SSP involved in cleavage are predictable
based on SPase specificity, those that promote SSP association
in the complex and GP-C-mediated membrane fusion are as-yet
undefined.
Discussion
The tripartite organization of the Junín virus GP-C complex
provides little precedent for understanding the structure and
function of SSP. Previous studies have shown that SSP
association is required for transit of the G1–G2 precursor
from the ER, and thereby for SKI-1/S1P maturation in the cis-
medial Golgi (Agnihothram et al., 2006; Eichler et al., 2003a).
The SSP subunit is also important for the pH-dependent
membrane fusion activity of the mature GP-C complex
(Agnihothram et al., 2006; York and Nunberg, 2006). In order
to better understand the biogenesis and function of the GP-C
complex, we have applied site-specific mutagenesis to the SSP
region recognized in the proteolytic cleavage of SSP from the
GP-C precursor.
Earlier studies of the Old World Lassa fever virus de-
monstrated that cleavage of the GP-C precursor to generate SSP
was abrogated by arginine substitutions at the −1 and −3
positions, consistent with known sequence requirements for
cleavage by the cellular SPase (Eichler et al., 2003b). In this
report we have extended the investigation to show that the
arginine mutation at position −1 likewise prevents cleavage of
the New World Junín virus GP-C, and further that substitutions
at residues −1 and −3 with alanine, an amino acid that is
preferred at these positions in known SPase recognition sites
(von Heijne, 1985), increase the efficiency of SSP cleavage. In
accordance with the known degeneracy of amino acids at the −2
position at SPase sites, replacements of C57 with either alanine
or serine were without effect on cleavage. Together, these
studies provide additional support to the notion that SSP
cleavage in the GP-C precursor is mediated by the cellular
SPase.
The T58R mutation that abrogates SPase cleavage of GP-C
also prevents SKI-1/S1P maturation of the precursor. This
finding was first reported using the same mutation in the Old
World Lassa fever virus (Eichler et al., 2003b). Here we
demonstrate that the mutation also prevents transit of the GP-C
precursor to the cell surface. Based on the role of SSP in quality
control for transport of the GP-C complex from the ER and to
the cell surface (Agnihothram et al., 2006), we speculate that the
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inability of the uncleaved GP-C precursor to transit from the
ER. It remains possible, however, that other quality control
mechanisms may affect intracellular transport of the uncleaved
GP-C precursor, or that SKI-1/S1P cleavage might be
conformationally impaired by the lack of cleavage (Eichler et
al., 2003b).
The basis for the effect of SSP cleavage on GP-C transport is
not known. We have previously shown that SSP interacts with
ER localization signals in the cytoplasmic domain of G2 in
controlling transit of the complex from the ER, and that the
ectodomain of G2 (and G1) is dispensable in this process
(Agnihothram et al., 2006). Here we show that the absence of
SPase cleavage in the T58R GP-C mutant also prevents binding
of wild-type SSP expressed in trans. This association in trans
may be prevented by the prior binding of the uncleaved SSP, in
which case the lack of transport may indicate that SPase
cleavage in the ER lumen is able to affect quality control
functions attributed to the cytoplasmic domain of GP-C.
Alternatively, retention of the T58R mutant may signal the
inability of any SSP to properly associate with GP-C prior to
SPase cleavage, such that ER localization signals in the
cytoplasmic domain of G2 remain active. This model would
also require that structural changes resulting from SPase
cleavage be transmitted within and through the membrane to
enable SSP association.
In considering the structure and function of SSP in the
maturing GP-C complex, the orientation of SSP within the
membrane becomes of central importance. Studies of SSP in the
Old World Lassa fever and LCM viruses have suggested a type
II membrane topology in which the N-terminus of SSP resides
in the cytosol and the C-terminus in the ectodomain (Eichler et
al., 2004; Froeschke et al., 2003). This model is reasonable in
light of myristoylation at the N-terminus (York and Nunberg,
2006) and SPase cleavage in the ER lumen. However, this initial
localization of the termini could change during biogenesis. For
instance, the myristoylated N-terminus of the large (L) surface
glycoprotein of hepatitis B virus (HBV) is translocated into the
lumen during HBV morphogenesis (Grgacic et al., 2000;
Lambert and Prange, 2001; Ostapchuk et al., 1994). Similarly,
the signal peptide regions of the hepatitis C virus envelope
glycoproteins E1 and E2 are thought to reorient into the cytosol
upon SPase cleavage of the polyprotein (Cocquerel et al., 2002).
It is also worth noting that the type II topology of membrane
proteins itself requires inversion of the signal anchor in the
translocon prior to membrane insertion (White and von Heijne,
2004). Specific protein–protein interactions in the nascent
protein prior to membrane insertion may likewise affect the
number and orientation of membrane-spanning regions (Borel
and Simon, 1996).
Further definition of the membrane-spanning topology of
SSP may also shed light on the existence and requirement for a
free cysteine side-chain at position −2. C57 is present in all
New World and Old World arenaviruses and the conservative
replacement of a single oxygen atom in the serine side-chain
disrupts the association of SSP in the GP-C complex. It is
possible that an unusually labile disulfide bond at C57 might goundetected in our in vitro experiments. Alternatively, stringent
side-chain requirements might distinguish between thiol and
hydroxyl moieties. In any case, the presence of a free thiol in the
oxidizing extracellular environment is unusual. Initial efforts to
probe whether C57 might exist as a thiolate have been unin-
formative as the C57D mutation (Gattis et al., 2004) did not
restore assembly (not shown). It is thus possible that C57 may
instead be buried in a membrane-spanning or cytosolic region of
SSP.
In contrast to the penultimate C57 residue, the C-terminus of
SSP (T58) can be varied extensively without effect on GP-C
assembly or membrane fusion activity. Substitution of T58 with
arginine, a large and positively charged residue, while
abrogating SPase cleavage, did not affect assembly of SSP in
trans or GP-C-mediated membrane fusion activity. Nor did
the C-terminal addition of a 15-residue Spep affinity tag. This
sequence flexibility is perhaps unlikely were the C-terminus of
SSP in proximity to the membrane fusion machinery in the
ectodomain of G2. By contrast, an Spep tag is well tolerated at
the cytoplasmic C-terminus of G2 (Agnihothram et al., 2006;
York et al., 2004, 2005).
Taken together, our results suggest the possibility that the C-
terminus of SSP in the GP-C complex may reside in the cytosol.
By this model, the C-terminus would be translocated from the
ER lumen upon SPase cleavage, resulting in bitopic insertion of
SSP in the membrane. The distinct requirements for SPase
cleavage and SSP function may thus reflect the dual roles of the
C-terminal SSP sequence in the ER lumen and upon
translocation to the cytosol.
The tripartite organization of the arenavirus GP-C complex is
unique among viral envelope glycoproteins. SSP association is
required both for intracellular trafficking of the G1–G2
precursor from the ER and for the pH-dependent membrane
fusion activity of the mature GP-C complex (Agnihothram et
al., 2006; York and Nunberg, 2006). As such, further
information regarding the structure and function of SSP may
suggest novel strategies for interfering in arenavirus replication
and disease.
Materials and methods
Molecular reagents, recombinant vaccinia viruses, and
monoclonal antibodies
The GP-C coding region from the pathogenic Junín virus
strain MC2 (Ghiringhelli et al., 1991) was provided by Victor
Romanowski (Universidad Nacional de La Plata, Argentina)
and introduced into the mammalian expression vector pcDNA
3.1+ and an innocuous S-peptide (Spep) affinity tag (Kim and
Raines, 1993) was appended to the C-terminus as described
(York et al., 2004). For trans-complementation studies
(Agnihothram et al., 2006; Eichler et al., 2003a; York and
Nunberg, 2006), a CD4sp-GPC construct in which SSP was
replaced by the conventional signal peptide of CD4 (York et al.,
2004) was co-expressed with an SSP construct in which a stop
codon was introduced following the C-terminal SSP amino acid
(SSP-term). The Spep affinity tag was appended to the C-
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Site-directed mutations were introduced by QuikChange
mutagenesis (Stratagene) and all constructs were verified by
DNA sequencing.
Optimal expression of the Junín virus GP-C gene and its
derivatives in Vero 76 cells was achieved using the bacterio-
phage T7 promoter of the pcDNA3.1 vector and infection by a
recombinant vaccinia virus expressing the T7 polymerase
(vTF7-3; Fuerst et al., 1986). The vaccinia virus vCB21R-
lacZ expressing the β-galactosidase gene under the control of
the T7 promoter (Alkhatib et al., 1996) was used in our analysis
of cell–cell fusion (Nussbaum et al., 1994). These recombinant
vaccinia virus reagents were provided by T. Fuerst and B. Moss,
and C. Broder, P. Kennedy and E. Berger, respectively, through
the NIH AIDS Research and Reference Reagent Program.
Mouse monoclonal antibody (MAb) GB03-BE08 (BE08)
(Sanchez et al., 1989), directed against the G1 subunit of GP-
C, was kindly provided by Drs. Tom Ksiasek and Tony Sanchez
(Special Pathogens Branch, CDC, Atlanta).
Expression of intact GP-C and trans-complemented derivatives
The glycoproteins were expressed and characterized as
previously described (Agnihothram et al., 2006; York et al.,
2004, 2005; York and Nunberg, 2006). Briefly, Vero 76 cells
were infected with the recombinant vaccinia virus vTF7-3
(Fuerst et al., 1986) at a multiplicity of two in Dulbecco's
minimal essential medium (DMEM) containing 2% fetal bovine
serum (FBS) and 10 μM cytosine arabinoside (araC) (Hruby et
al., 1980). After 30 min, the cells were washed and transfected
with either the intact GP-C expression plasmid or, in trans-
complementation studies, a 3:1 ratio of CD4sp-GPC and SSP-
term plasmids using Lipofectamine 2000 reagent (Invitrogen).
Metabolic labeling using 32–50 μCi/ml of [35S]-ProMix
(Amersham Pharmacia Biotech) was initiated 6 h post-trans-
fection in methionine- and cysteine-free medium containing
10% dialyzed FBS and 10 μM araC, and was continued for 12–
16 h. Cultures were then washed in physiological buffered
saline (PBS) and lysed using cold Tris–saline buffer (50 mM
Tris–HCl and 150 mM NaCl at pH 7.5) containing 1% Triton
X-100 nonionic detergent and protease inhibitors (1 μg/ml each
of aprotinin, leupeptin, and pepstatin). The expressed glyco-
proteins were isolated from cleared lysates by immunoprecip-
itation using the G1-directed MAb BE08 and protein A–
Sepharose (Sigma) or via the C-terminal Spep affinity tag using
S-protein agarose (Novagen). Isolated glycoproteins were
deglycosylated using peptide:N-glycosidase F (PNGase F,
New England Biolabs). Proteins were analyzed by SDS-
polyacrylamide gel electrophoresis using NuPAGE 4–12%
Bis–Tris gels (Invitrogen) and the recommended sample buffer
containing lithium dodecylsulfate and reducing agent. The
reducing agent (Invitrogen) was omitted for denaturing PAGE
analysis under non-reducing conditions. Molecular size markers
included [14C]-methylated Rainbow proteins (Amersham
Pharmacia Biotech). Radiolabeled proteins were imaged using
a Fuji FLA-3000 G imager and analyzed using ImageGauge
software (Fuji).Flow cytometry
Vero 76 cells expressing GP-C or its derivatives were
labeled using the G1-specific MAb BE08 (Sanchez et al.,
1989) and a secondary fluorescein isothiocyanate (FITC)-
conjugated goat anti-mouse antibody (Jackson ImmunoRe-
search). Cells were subsequently stained using propidium
iodide (1 μg/ml) to exclude dead cells and fixed in 2%
formaldehyde (York et al., 2005). Populations were analyzed
using a FACSCalibur flow cytometer and CellQuest software
(BD Biosciences).
GP-C-mediated cell–cell fusion
The β-galactosidase fusion reporter assay (Nussbaum et al.,
1994) was used to characterize the ability of the envelope
glycoproteins to mediate pH-dependent cell–cell fusion (Agni-
hothram et al., 2006; York et al., 2004, 2005; York and
Nunberg, 2006). Briefly, Vero cells infected with vTF7-3 and
expressing GP-C were co-cultured with reporter cells infected
with vCB21R-lacZ, a recombinant vaccinia virus expressing β-
galactosidase under the control of the T7 promoter (Alkhatib et
al., 1996). The reporter cells were obtained by incubating Vero
76 cells with vCB21R-lacZ at a multiplicity of two and allowing
the infection to proceed overnight in the presence of 100 μg/ml
rifampicin (Hruby et al., 1980). The GP-C-expressing cells and
reporter cells were co-cultured in medium containing both araC
and rifampicin for 5 h and then subjected to a 30-min pulse of
neutral or acidic (pH 5.0) medium. β-Galactosidase expression
is induced upon fusion of the effector and reporter cells and was
detected, after 5 h of continued cultivation at neutral pH, in cell
lysates (Tropix) using the chemiluminescent substrate Galacto-
Lite Plus (Tropix). Cell–cell fusion was quantified using a
Tropix TR717 microplate luminometer.
Candid #1 strain of Junín virus
The attenuated vaccine strain of Junín virus, Candid #1
(Albarino et al., 1997; Barrera Oro and McKee, 1991;
Maiztegui et al., 1998), was kindly provided by R. Tesh,
WHO Reference Center for Arboviruses (University of Texas
Medical Branch) and was propagated in Vero cells under
Biosafety Level 2 conditions (Centers for Disease Control and
Prevention, 1999). Cultures infected with Candid #1 virus were
labeled for 18 h starting 5 days after infection with a multiplicity
of approximately 0.5 focus-forming units per cell (York et al.,
2004). Virions were purified by ultracentrifugation through
20% sucrose and solubilized in Triton X-100-containing cell
lysis buffer for immunoprecipitation.
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